What is Agios Pharmaceuticals, Inc.'s Market Cap?

Agios Pharmaceuticals, Inc.'s Market Cap is $2.2B, based on as-reported figures from SEC (XBRL) filings.

What is Agios Pharmaceuticals, Inc.'s Price / Sales?

Agios Pharmaceuticals, Inc.'s Price / Sales is 22.5×, based on as-reported figures from SEC (XBRL) filings.

What is Agios Pharmaceuticals, Inc.'s Revenue (TTM)?

Agios Pharmaceuticals, Inc.'s Revenue (TTM) is $98.3M, based on as-reported figures from SEC (XBRL) filings.

What is Agios Pharmaceuticals, Inc.'s Net Income (TTM)?

Agios Pharmaceuticals, Inc.'s Net Income (TTM) is -$411.3M, based on as-reported figures from SEC (XBRL) filings.

What is Agios Pharmaceuticals, Inc.'s EBITDA?

Agios Pharmaceuticals, Inc.'s EBITDA is -$453.8M, based on as-reported figures from SEC (XBRL) filings.

What is Agios Pharmaceuticals, Inc.'s Diluted EPS (TTM)?

Agios Pharmaceuticals, Inc.'s Diluted EPS (TTM) is -6.89, based on as-reported figures from SEC (XBRL) filings.

What is Agios Pharmaceuticals, Inc.'s EBITDA Margin?

Agios Pharmaceuticals, Inc.'s EBITDA Margin is -461.5%, based on as-reported figures from SEC (XBRL) filings.

AKYLA/ Financials

Equity / PHARMACEUTICAL PREPARATIONS

Agios Pharmaceuticals, Inc.

XNAS · usd

SIC 2834 · PHARMACEUTICAL PREPARATIONS

FIGI BBG001T8R687

37.00▼ 0.19 (-0.51%)

As of 2026-10-23

Price / Volume

Valuation

Market Cap
Enterprise Value: —
Trailing P/E: —
Price / Sales
EV / Revenue: —
EV / EBITDA: —

Financial Highlights

Revenue (TTM)
Net Income (TTM)
EBITDA
Diluted EPS (TTM)
EBITDA Margin
Net Debt: —

Trading Information

Previous Close: 37.19
Day's Range: 36.10 – 37.32
52-Week Range: 22.24 – 46.00
Volume: 913.2K
Avg Volume: 1.0M

Share Statistics

Shares Outstanding
Employees: 540
Exchange: XNAS
Listed: 2013-07-24

Share count as of July 24, 2026

Agios Pharmaceuticals, Inc. (AGIO) Financial Statements

View

Income Statement

Detail

Standard

Period

Quarterly

Loading Income Statement…

Key questions about Agios Pharmaceuticals, Inc. (AGIO)

What is Agios Pharmaceuticals, Inc.'s Market Cap?: Agios Pharmaceuticals, Inc.'s Market Cap is $2.2B, based on as-reported figures from SEC (XBRL) filings.
What is Agios Pharmaceuticals, Inc.'s Price / Sales?: Agios Pharmaceuticals, Inc.'s Price / Sales is 22.5×, based on as-reported figures from SEC (XBRL) filings.
What is Agios Pharmaceuticals, Inc.'s Revenue (TTM)?: Agios Pharmaceuticals, Inc.'s Revenue (TTM) is $98.3M, based on as-reported figures from SEC (XBRL) filings.
What is Agios Pharmaceuticals, Inc.'s Net Income (TTM)?: Agios Pharmaceuticals, Inc.'s Net Income (TTM) is -$411.3M, based on as-reported figures from SEC (XBRL) filings.
What is Agios Pharmaceuticals, Inc.'s EBITDA?: Agios Pharmaceuticals, Inc.'s EBITDA is -$453.8M, based on as-reported figures from SEC (XBRL) filings.
What is Agios Pharmaceuticals, Inc.'s Diluted EPS (TTM)?: Agios Pharmaceuticals, Inc.'s Diluted EPS (TTM) is -6.89, based on as-reported figures from SEC (XBRL) filings.
What is Agios Pharmaceuticals, Inc.'s EBITDA Margin?: Agios Pharmaceuticals, Inc.'s EBITDA Margin is -461.5%, based on as-reported figures from SEC (XBRL) filings.

Akyla / Financials · AGIOAs-filed SEC (XBRL) data